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Introduction: Perinatal Mood and Anxiety Disorders (PMADs) are a significant public health 
concern in the United States, impacting a large number of women every year and representing 
the most common complication of pregnancy. Despite efforts at increasing screening and 
treatment, more than half of women experiencing PMADs go undetected or undiagnosed. 
Integrated behavioral health care (IBHC), a patient-centered and population-based coordination 
of mental and physical health care, is a promising avenue for improving the screening and 
treatment of PMADs. IBHC in perinatal settings where women frequent during pregnancy or 
postpartum may decrease barriers to accessing and receiving behavioral health screening and 
treatment. The objective of this literature review was to understand the current evidence for the 
use of IBHC in perinatal settings.  
Methods: The search strategy for this literature review was created iteratively with the help from 
two librarians. Key terms for the search strategy included integrated care, collaborative care, 
pregnancy, postpartum, perinatal period, maternity, mental health, and behavioral health. Three 
databases were searched: PubMed, PsychINFO, and Scopus. Inclusion criteria were 1) pregnant 
and/or postpartum women as subjects, 2) perinatal settings 3) adult patients, 4) English language, 
5) description of an integrated care intervention, 6) setting within the United States, 7) at least 
one outcome measured, and 8) original research. 
Results: The search resulted in the identification of 1,180 records (PubMed 392, Scopus 572, 
and PsychINFO 216). After duplicates were removed, results were screened first at the title and 
abstract level. Full text review was then conducted on 82 articles, and 37 studies were included 
in the final synthesis. Studies reported on feasibility, acceptability, and effectiveness outcomes in 
varying manners. All but two studies reported screening with a validated tool. Patient 
populations included diverse groups such as low-income women, Latina women, African 
American women, and female veterans. Studies that reported on acceptability found 
interventions to be acceptable for both patients and providers. Several of the studies that included 
effectiveness outcomes reported increased depression remission and improved depression 
symptoms among women in the intervention groups.  
Conclusion: Integrated behavioral health care (IBHC) interventions are feasible, acceptable, and 
effective at treating perinatal mood and anxiety disorders among diverse populations and settings 
in the United States. Despite limited homogeneity among interventions and outcome variables, 
IBHC models pose a unique opportunity for health care professionals to improve screening and 
treatment of depression and mood disorders among pregnant and postpartum women. Additional 






Integrated Behavioral Care Models: Improving the Screening and Treatment of Perinatal 
Mood and Anxiety Disorders 
 
INTRODUCTION 
Perinatal Mood and Anxiety Disorders (PMADs) are the most common complication of 
pregnancy and the leading cause of morbidity and mortality among childbearing women.1,2 
PMAD is an umbrella term encompassing various mood and anxiety disorders that occur during 
the perinatal period, which refers to pregnancy and the postpartum period (up to one year 
following child birth).3–5 While these symptoms and disorders can occur at any point during life, 
there is an increase in their prevalence during pregnancy and postpartum.6 PMADs include 
Depression, Anxiety, Panic Disorder, Obsessive-Compulsive Disorder, Posttraumatic Stress 
Disorder, Bipolar Disorder, and Psychosis.6,7 
Prevalence of Perinatal Mood and Anxiety Disorders 
Postpartum Depression is the most common PMAD for women following childbirth, 
impacting approximately one in seven women.6,8 Best prevalence estimates for women 
experiencing depression at some point during their pregnancy or postpartum range from 10% to 
22%, while approximately 40-60% of new mothers may experience anxiety symptoms alongside 
depressive symptoms during the perinatal period.1,2,4,7,8 Anxiety prevalence estimates are 13-21% 
for the prenatal period and 11-17% during the postpartum period.6,9 Annually, 950,000 American 
women report experiencing symptoms of Postpartum Depression, which is higher than the 
800,000 women affected by diabetes and the 232,000 women diagnosed with breast cancer each 
year.1  
There is mixed evidence on whether or not the prevalence of PMADs may be larger 
among racial and ethnic minority women; although some research has indicated that the 
prevalence of PMADs among racial and ethnic minority women is substantially higher than 
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among white women, other studies that have conducted universal screening found the PMAD 
prevalence across racial groups to be similar.10–12 Regardless of potential prevalence differences, 
there is evidence that PMADs among racial and ethnic minority women are more likely to go 
undetected or undiagnosed, and these women are less likely to initiate, follow-up, and continue 
with treatment or care.10,13 Disparities in depression care among racial and ethnic minority 
women are also well-documented in the literature.14–16 
Despite the high prevalence estimates for perinatal depression and anxiety, researchers 
estimate that overall approximately 50% of women experiencing PMADs go undetected or 
undiagnosed, indicating the scope of the problem to be larger than the current understanding.1,7 
This has serious consequences on the lives of mothers and babies, and the impacts of untreated 
PMADs is explained in the next section of this paper. Even those women who do receive a 
diagnosis may not seek or receive appropriate mental health services due to stigma, inadequate 
insurance coverage for mental health services, a lack of accessible mental health resources or 
services, and insufficient follow-up or standardized processes for mental health care 
treatment.17,18 The prevalence estimates themselves likely vary for similar reasons, and also 
because of a lack of PMAD attention or surveillance in some medical settings, and inconsistent 
screening practices.1,9,19 A systematic review of depression care for pregnant and postpartum 
women found that an average of only 22% of women who screened positive for depression used 
mental health care treatment and services, and far fewer engaged in sustained mental health 
treatment.20 The Health Resources and Services Administration (HRSA) reported 119 million 
Americans living in health professional shortage areas for mental health, and needing an 




Impact of Untreated Perinatal Mood and Anxiety Disorders  
Untreated PMADs impact the health of both mothers and their babies in the short- and 
long-term. Mothers may demonstrate poor self-care, inadequate or inconsistent parenting, or 
poor responsiveness to their child; they are also at risk for developing other mood disorders, 
substance use disorders, and tobacco and alcohol use, and are at risk for a variety of pregnancy 
complications and suicide.4,22,23 Suicide is a particularly concerning and violent risk from 
untreated PMADs, and is the second leading cause of maternal death in more developed 
countries.24–26 Impaired mother-infant bonding may occur, which contributes to babies showing 
less positive affect, withdrawal behavior, and increases in drowsiness and fussiness; long-term, 
these children have an increased risk for impaired mental and motor development, as well as 
poor self-regulation.4,22,23 Infants of mothers experiencing PMADs are at a greater risk of 
developing an insecure attachment style, which impacts their relationships throughout the 
lifetime.23 
Perinatal Mood and Anxiety Disorders not only represent a significant public health 
concern due to their negative impact on the lives of women and children, but untreated PMADs 
also result in a significant economic burden in the United States. The estimated cost of untreated 
PMADs in the US for the 2017 birth cohort is $14 billion, from conception to five years.27 
Mothers incur the larger part of these costs at 65%, while the child incurs 35%. The largest of 
these costs are attributed to decreased productivity of mothers, more preterm births, and 
increases in other maternal health expenditures.27   
Integrated Behavioral Health Care 
Integrated Behavioral Health Care (IBHC) broadly refers to the integration and 
coordination of behavioral health services with primary health care.28 IBHC may be best 
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understood as a spectrum of integration between health care practices, and it includes various 
models such as behavioral health consultation, collocation of primary and mental health care 
providers in one setting, care managers to systematically screen and follow-up with patients, and 
full integration of services and patient records, as outlined by the SAMSHA-HRSA Center of 
Excellence for Integrated Health Solutions.29 All models of IBHC emphasize client-centered and 
population-based care, and models stress the importance of regular screening and outcome 
monitoring using validated tools, allowing clinicians to measure and track scores over time.29,30 
One specific model of IBHC that is important to highlight because of its success is the 
Collaborative Care (CoC) Model, which was developed by the University of Washington AIMS 
Center. In this model, a care manager, located within a primary health care setting, monitors a 
caseload of patients and manages their treatment and follow-up based on recommendations from 
a psychiatric consultant; the primary care doctor continues to be the main point of contact for the 
patient, and also acts on treatment recommendations from the psychiatric consultant, including 
the prescription of any medications.30 The CoC Model has more than 80 randomized controlled 
trials supporting its effectiveness for depression treatment in adults over usual care.30–32 While 
this model has been shown to be highly effective, it does require the implementation of specific 
screening guidelines, tracking systems, and the new roles of care manager and psychiatric 
consultant; these upfront costs and other initial efforts that are required may make it difficult for 
some health care practices to carry out all necessary components of this models. Because of this 
barrier, it is important to study all levels of integration of care so that practices may find and 
apply what works for them, and then work toward full integration in the long run.  
IBHC models pose a unique opportunity for the public health problem of untreated 
PMADs. The spectrum of IBHC models has been studied across diverse populations, health care 
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settings, and specific health issues, with extensive evidence supporting their efficacy in treating 
depression in adult populations, and more emerging evidence with other populations and mental 
health concerns.28,33,34 Therefore, an integrated approach to health care is a promising method for 
combating the issues of high PMAD prevalence, inconsistent screening practices, the shortage of 
mental health care providers, and the barriers associated with accessing and receiving care for 
mental health concerns during pregnancy and postpartum.5,35 IBHC may be particularly effective 
at reducing barriers for racial and ethnic minority women; patient-centered communication, 
systematic screening and follow-up, and patient engagement strategies are all optimal practices 
for reducing disparities in mental health detection and treatment.36 Additionally, IBHC models 
within primary or obstetric settings where women are receiving their prenatal or postpartum care 
would be exceptionally positioned to impact a large portion of this population, as women have 
frequent contact with health professionals during this time period.37 
Literature Review Objectives  
While an extensive evidence base has been established for the use of integrated care with 
the general adult population, fewer studies and reviews have focused specifically on the perinatal 
population. A systematic review by Simas et al.18 thoroughly compiled the available evidence 
from 21 articles for IBHC models with the perinatal population up through 2017, and it is a key 
paper demonstrating the success of IBHC models with this population. This review stands alone 
from the Simas paper, however, while also adding to the evidence base in several ways. First, 
this paper explores the use of IBHC models in perinatal settings specifically within the United 
States, while Simas et al. reviewed both domestic and global IBHC model interventions with 
pregnant and postpartum women. Second, this review includes all PMADs, and does not 
exclusively focus on perinatal depression. Third, the inclusion of equity in IBCH interventions is 
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explicitly examined in this review, which has not been adequately addressed in any other review 
on this topic. Lastly, this paper adds an additional three years of evidence to the papers reviewed 
by Simas et al., including the most up to date evidence for IBHC models with pregnant and 
postpartum women. As the use of these models with the perinatal population has only begun to 
gain momentum more recently, it is important to continue to review the most recent 
interventions. By addressing all of these factors, this literature review seeks to build the strongest 
case possible for using IBCH models with all pregnant and postpartum women in the United 
States to effectively address Perinatal Mood and Anxiety Disorders. 
METHODS 
Search Strategy 
The search strategy for this literature review was developed iteratively with assistance 
from two librarians from the Health Science Library at the University of North Carolina at 
Chapel Hill. Searches were conducted in three databases, PubMed, Scopus, and PsychINFO, in 
September 2020. The search string included key words and concepts such as integrated care, 
collaborative care, mental health, behavioral health, perinatal period, postpartum, prenatal, and 
pregnancy. The specific search strings for the three databases are indicated in Table 1. Additional 
sources were hand searched by reviewing references of systematic reviews and key papers.  
Table 1. Search Strategies for the literature review. 
Search String Database 
((“Delivery of Health Care, Integrated"[Mesh] OR “integrated care”[tiab] OR 
“collaborative care”[tiab] OR integrated[tiab] OR collaborative[tiab]) AND 
("Behavioral Medicine"[Mesh] OR "Mental Health"[Mesh] OR "behavioral 
health"[tiab] OR "mental health"[tiab]) AND ("Perinatal Care"[Mesh] OR 
"Postpartum Period"[Mesh] OR "Prenatal Care"[Mesh] OR "Pregnancy"[Mesh] 
OR perinatal[tiab] OR postpartum[tiab] OR prenatal[tiab] OR peripartum[tiab] 
OR antepartum[tiab] OR antenatal[tiab] OR postnatal[tiab] OR maternal[tiab] 
OR maternity [tiab] OR pregnant[tiab] OR pregnancy[tiab])) 
PubMed 
((“integrated care” OR “collaborative care” OR integrated OR collaborative) 
AND ("behavioral medicine" OR "behavioral health" OR "mental health") AND 
(perinatal OR postpartum OR prenatal OR peripartum OR antepartum OR 
antenatal OR postnatal OR maternal OR maternity OR pregnant OR 
pregnancy)) 
Scopus and PychINFO 
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Inclusion and Exclusion Criteria 
 
 Inclusion criteria for papers were as follows: 1) pregnant and/or postpartum women as 
subjects, 2) perinatal settings (including OB/GYN, family medicine, primary care, pediatric, or 
midwifery clinics), 3) adult patients (ages 18 or older), 4) English language, 5) description of an 
integrated care intervention, 6) setting within the United States, 7) at least one outcome measured 
(effectiveness, feasibility, or acceptability), and 8) original research. A description of the 
outcomes and the reasons for their selection is given later this paper. While substance use and 
chronic medical illnesses like HIV can impact PMADs, articles that primarily focused on 
substance use or chronic diseases during pregnancy and postpartum were excluded in order to 
maintain the focus on PMADs amongst the general US population of pregnant and postpartum 
women. Systematic reviews or meta-analyses were also excluded, as were opinion pieces or 
commentary articles. Previous systematic reviews on IBHC models have included interventions 
in other countries;18 therefore, given the unique nature of the health care and insurance system in 
the United States, and the author’s desire to generalize results to women in the US, interventions 
taking place outside of the US were excluded. 
Components of Integrated Care 
 Studies were included that had some description of an integrated care intervention. Given 
the spectrum of integrated care models, a list of various components of IBHC was compiled 
based on the AIMS Center Collaborative Care components, the SAMSHA-HRSA definition, and 
criteria from previous systematic reviews of integrated care models with the perinatal 
population.18,29,30 Interventions had to contain at least one of the components of IBHC in order to 
be included in this paper. A complete list of integrated care components is included in Table 2.  
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Table 2. Components of Integrated Behavioral Health Care (IBHC) interventions. 
Component Description 
Patient-centered team care The primary care provider/OB/pediatrician and mental health provider 
collaborate on patient goals and use shared care plans. 
Population-based care A caseload of patients is defined and tracked in a medical registry. 
Measurement-based 
treatment 
Symptoms are measured using validated tools, which are regularly used in 
follow-up to track treatment progress. If improvement is not seen, treatment 
plans are changed. 
Evidence-based care Treatment options, including pharmacotherapy, psychotherapy (ex. Interpersonal 
Therapy, Problem-Solving Therapy), patient psychoeducation, and/or patient 
engagement strategies (ex. use of toolkits/algorithms to discuss mental health) 
are grounded in evidence and research. 
Accountable care Reimbursement for providers is based on care quality outcomes and not solely 
volume 
Collocated behavioral health 
services 
Mental health services are provided in the same location as primary 
care/OB/pediatric services. 
Access to mental health 
consultation  
The patient and/or the provider have access to mental health consultation from a 
psychiatrist or other mental health professional. This can be provided either face-
to-face or remotely (telepsychiatry).  
Systematic provision of 
resources and/or referrals 
All patients experiencing mental health concerns receive mental health resources 
and/or referral information. 
 
Outcomes 
 All included studies reported at least one outcome on feasibility, acceptability, and/or 
effectiveness. These multiple types of outcomes were selected in order to include a broad variety 
of studies in the literature review, such as pilot studies and feasibility studies. Given that the 
majority of the research on IBHC models with the perinatal population has been within the past 
10 years, it was important to optimize the number of studies that could be included in this 
review. Additionally, by reporting on all three outcomes, a stronger case could be made for the 
use of IBHC with pregnant and postpartum women. Feasibility outcomes establish the 
interventions’ logistical viability for patients, practices, and providers, while acceptability 
outcomes demonstrate how well an intervention is received by either the target population, health 
care providers, or both. Effectiveness outcomes provide evidence of the interventions’ impact on 
mental health treatment and behavioral health changes. Table 3 indicates the various outcome 
questions that studies could include to assess feasibility, acceptability, and effectiveness.  
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Table 3. Possible questions to assess feasibility, acceptability, and effectiveness outcomes. 
 
Equity 
 Equity was considered separately from the other three outcomes listed above, given that 
equity measures could overlap with feasibility, acceptability, and effectiveness outcomes, or be 
demonstrated separately from those outcomes. The presence of equity components in an 
intervention was also not incorporated in the inclusion criteria, given the author’s assumption 
that this choice could too narrowly limit the literature included in this review. Table 4 includes 
the various questions that were used to asses equity in this review. 




Feasibility Was mental health screening performed using a validated tool? 
Was an assessment performed to confirm the diagnosis? 
Did the patient meet with the provider or mental health manager to discuss screening results? 
Was a referral for mental health treatment made? 
Was provider and/or practice utilization measured? 
Were intervention costs or other financial feasibility measures indicated? 
 
Acceptability Were patients satisfied with the intervention or treatment? 
Were providers satisfied with the intervention? 
Were providers confident in their ability to effectively treat patients for perinatal mental health 
concerns? 
Did providers have the knowledge and skills to detect and address perinatal mental health 
issues? 
 
Effectiveness Was mental health treatment initiated? 
Was mental health education/psychoeducation initiated? 
Was mental health treatment sustained? 
Was there evidence of improved symptoms or behavior change? 
Were any other outcomes improved? 
 Questions 
Equity Did the intervention target a specific high-risk population or group? 
Were vulnerable populations or groups included in the study population? 
Were patients from vulnerable populations satisfied with the intervention or treatment? 
Were providers serving at-risk patients satisfied with the intervention or treatment? 
Did the intervention include components of cultural competency? 
Was there evidence of improved symptoms or behavior change amongst vulnerable groups? 
Was there evidence of differences in improved symptoms or behavior change amongst high-risk 




All citation information from the searches within the three databases was uploaded into 
Mendeley, a citation manager. Duplicates were removed within Mendeley, using the 
deduplication tool. Articles were then uploaded into the review application Covidence, and were 
initially screened at the title and abstract level based on the inclusion criteria. The full text of all 
studies that appeared to meet the eligibility criteria were then further reviewed for final 
determination.   
RESULTS 
 The search strategy resulted in the identification of 1,180 records (PubMed 392, Scopus 
572, and PsychINFO 216). Additional records (10) were identified by handsearching reference 
lists from key articles. After duplicates were removed, a total of 694 records were screened at the 
title and abstract level for relevance, resulting in the exclusion of 612 records. Eighty-two full-
text articles were then assessed for eligibility. During full text review, 45 articles were excluded 
for various reasons, including non-adult population, lack of clear study outcomes, being 
systematic reviews, and non-perinatal settings or populations. A total of 37 articles were deemed 
to meet all inclusion criteria. A detailed list of studies, including author, intervention design, 
sample, and key outcomes, is included in Appendix A. The methodology and process for this 




Table 5. PRISMA Diagram 
 
 Articles ranged in study design, and included pilot studies (8),5,38–44 feasibility studies 
(5),45–49 retrospective and prospective cohort studies (10),35,50–57 randomized controlled trials 
(10),10,58–66 quality improvement (1)67 and open treatment trials (2)68,69. Several interventions 
were discussed multiple times in the literature: four articles were on the MOMCare Collaborative 
Care intervention by Grote et al.,60–63 two articles reported on the DC-Hope intervention,64,66 
three articles discussed the Depression Attention for Women Now (DAWN) Collaborative Care 
intervention or a modified version of DAWN,10,68,69 and three interventions involved the 
Partnership for Women’s Health Model (PWH) or a culturally competent expansion of PWH 
called the Perinatal Mental Health Model (PMH)38,45,46. There were also two articles found on 
MCPAP for Moms, the Massachusetts-based telepsychiatry consultation program, however one 
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article reported solely on MCPAP for Moms50 and one article compared the efficacy of the 
MCPAP for Moms program with a new intervention (PRISM).59 
 Study settings included obstetric practices, pediatric practices, a Veterans Affairs (VA) 
medical center, federally qualified health centers, hospital/medical systems, primary care 
facilities, family medicine clinics, public health centers, and fully integrated practices. Eleven 
different states were represented in the studies from various regions in the United States, and 
included both urban and rural settings.  
 All articles detailed an integrated care intervention. Byatt et al.50 and Marcus et al.53 
discussed a psychiatric consultation program for obstetric, primary care, and pediatric providers, 
and two other interventions included some form of behavioral health consultation.42,43 Grote et 
al.,60–63 Bhat et al.,68,69 Gjerdinger et al.,39 Katon et al.,65 Melville et al.,10 and Truitt et al.56 
reported on a Collaborative Care Model intervention. Collocation of behavioral health providers 
within primary, pediatric, or obstetric settings was the main intervention in 10 
studies.5,35,40,44,51,52,55,57,67,70 
 Despite having the intention for this review to contain interventions that addressed all 
PMADs, the primary focus of all but two of the articles was on perinatal depression. Katz et al. 
and Joseph et al. reported on behavior risk factors among African American women in 
Washington, D.C., which included depression, interpersonal violence, environmental tobacco 
smoke exposure, and smoking. Other interventions did seek to address other PMADs, such as the 
telepsychiatric consultation programs, however these articles did not demonstrate any of the 
feasibility, acceptability, or effectiveness outcomes for PMADs other than depression.50,53 Grote 
et al. investigated the impact of comorbid PTSD on depression severity as a secondary outcome 
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in the MOMCare Collaborative Care intervention versus usual care; however, the primary 
outcome of interest was still perinatal depression severity.60 
Feasibility 
 All articles except two reported screening for depression using a validated tool; 14 
interventions utilized the Edinburgh Postnatal Depression Scale (EPDS),5,35,38,41,42,44–
46,48,51,55,57,67,70 11 programs used the Patient Health Questionnaire-9 (PHQ-9),10,39,49,54,60–63,65,68,69 
and six studies reported using some combination of either the EPDS or the PHQ-9, or both 
tools.43,47,50,52,56,59 Two programs utilized the Beck Depression Inventory II and the Hopkins 
Symptom Checklist,64,66 and one clinic employed the US Preventive Services Task Force 2-Item 
Screener.40 The two studies that did not report using a validated tool included an article by Bhat 
et al.58 that focused primarily on a novel implementation strategy to support an IBHC 
intervention and an article on a telepsychiatry consultation program in Michigan.53 EPDS cutoff 
scores for depression ranged throughout the studies, but most used the cutoff score of 10.  
 While many articles discussed attending to all of the mental health needs of the pregnant 
and postpartum patients, the vast majority of them only included systematic screening for 
perinatal depression as a component of the intervention. The only articles that systematically 
screened for a disorder other than depression was Katz et al. and Joseph et al., which used the 
Hopkins Symptom Checklist.64,66 This validated tool includes questions to assess for anxiety as 
well as depression. Grote et al. used the Posttraumatic Stress Disorder Checklist-Civilian Version 
tool to assess PTSD severity; however, as mentioned earlier, PTSD severity was a secondary 
outcome in this study, while depression severity was the primary outcome of interest.60 
Some articles reported feasibility solely by stating the use of a validated screening tool; 
others reported a variety of different feasibility outcomes. Miller et al. found an increase in 
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screening rates with the PHQ-9 from before and after the intervention (65.2% of women 
screened prior to intervention, 93.5% screened after), as well as an increase in the rates of 
clinician-performed assessments following positive screens (from 10% prior to 85% after).54 
Rates of perinatal depression screening from other interventions ranged from 54%47 to 100%.43 
Referrals for mental health treatment and/or meeting with the provider or care manager to 
discuss screening results were other ways articles reported on feasibility outcomes. Flynn found 
67% of screen-positive women reported discussing their depression screen with their physician,51 
and Tourtelot reported 18 of the providers within one OB clinic having documented plans for 
addressing the depressive symptoms of their patients.70 Byatt et al. found that telephone 
consultation resulted in a variety of outcomes demonstrating feasibility including: referral to a 
psychiatrist (18%), care coordination (36%), and referral for therapy (38%).50 The intervention 
by Puryear et al. found that 3,893 of the 6,487 screen-positive women were referred for 
treatment.42 
Of the seven women who screened positive in the Connelly et al. study, the mental health 
advisor reached five by phone and administered a structural clinical interview.46 Truitt et al.,56 
Sit et al.,44 and Venkatesh et al.57 reported referring all women with positive screens for a mental 
health evaluation, and two of these were on-site evaluations with a collocated mental health 
professional.44,57 Shore et al. referred all patients with elevated scores to a care manager for 
program services, and the care manager made 834 contacts with the patients, which was an 
average of six contacts per patient.43 
Cost as a measure of feasibility was reported in only three articles.50,61,63 Byatt et al. 
found the total operating costs of the MCPAP for Moms program to be $8.38 per perinatal 
woman per year, or $0.70 per month.50 This reported cost was to run the program for the entire 
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state of Massachusetts per year, or $600,000 for 71,618 deliveries annually. 50 It did not include 
start-up administrative expenses or community capacity building. Grote et al. estimated a cost of 
$1,117 per patient, assuming $80 for each depression care specialist visit, $31 for each telephone 
contact with the depression specialist, and a fixed cost of $247 per patient for caseload 
supervision and support; the overall cost of the intervention delivered over 18 months was about 
$2.50 per day.61 In a later article, Grote et al. also analyzed the incremental benefit-cost of the 
MOMCare Collaborative Care intervention by assigning a value of $20 for every depression free 
day (DFD).63 Women with comorbid PTSD particularly benefited from the MOMCare 
intervention, as they experienced 68 more DFDs versus women in the usual care group, which 
resulted in an incremental net benefit of $48.50 Lastly, the intervention by Lomonaco-Haycraft et 
al. did not report on specific costs, but stated that same-day billing and other billing changes 
related to IBHC codes allow for the financial sustainability of these types of programs.35 
Acceptability 
 The majority of the 37 articles (25) reported acceptability outcomes for the interventions. 
Six articles noted that patients in the integrated care intervention group were more satisfied with 
the quality of their depression care as compared with the usual care group,10,60–63,65 and four other 
articles reported patients were satisfied or very satisfied with the intervention.39,43,44,49 Baker-
Ericzen et al. found that 97% of the low-income Latina mothers in the intervention found their 
mental health advisor to be knowledgeable about depression, and 100% rated the mental health 
advisor services as high quality; over 30 of these mothers also spontaneously commented about 
how the intervention had impacted their understanding of depression and the cultural barriers 
related to depression.45  
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In Connelly et al., 100% of the moms, who were predominately low-income and Latina, 
reported high satisfaction with their contact with the mental health advisor.46 Other studies also 
commented on patients’ satisfaction with their mental health advisor, care manager, or provider; 
93% of the surveyed subsample of the African American women enrolled in the Joseph et al. 
DC-Hope intervention had a positive view of their relationship with their care manager.64 
Patients in an urban obstetrics clinic serving a majority Medicaid-eligible population reported 
appreciating having their provider talk with them about their symptoms and felt supported.70  
Articles also reported on providers’ acceptability to the intervention. In Byatt et al., 
providers enrolled in the MCPAP for Moms group and the PRogram in Support of Moms 
(PRISM) group stated they had increased knowledge and skills to detect and address depression 
in the perinatal population; the percentage of providers certain in their ability to effectively treat 
OB patients with depression increased in both groups, but there was higher increase in the 
PRISM group.59 Most providers (87%) in the modified DAWN collaborative care intervention 
felt that the intervention had improved clinical outcomes.69 In a fully integrated obstetric clinic in 
the northwestern United States, providers reported perceiving the clinic to be helpful and 
improved access to mental health care.52 
Effectiveness 
Thirty-two of the articles reported at least one effectiveness outcome. Several studies 
indicated depression symptom improvement or decreased EPDS scores among patients: Byatt et 
al. found that EPDS scores improved in both the MCPAP for Moms group and the PRISM 
group, but they improved more in the PRISM group.59 Women who participated in the 
MOMCare collaborative care intervention by Grote et al. had significantly higher rates of 
depression remission and lower levels of depression severity compared to the usual care 
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group.60–62 Both the MOMCare group and the usual care group also saw a reduction in comorbid 
PTSD symptoms over time, but those with comorbid PTSD in MOMCare versus usual care 
experienced greater improvement in depression severity.63 Melville et al. found that women in 
the intervention group had a greater reduction in depression symptoms at 12 and 18 months, and 
these patients were more likely to have at least a 50% decrease in depressive symptoms at 12 
months.10 
Articles also reported on effectiveness by indicating the number or percentage of patients 
linked to or receiving behavioral health treatment or services. Puryear et al. had 55.8% of the 
3,893 referrals complete at least one mental health appointment within 60 days of the referral.42 
Among the women who screened positive in the Miller et al. 2012 study in Illinois, 90% entered 
mental health treatment after the intervention.54 Women enrolled in the DAWN intervention by 
Melville et al. were more likely to receive at least four specialty mental health visits as compared 
to the usual care group.10 In the PMH model by Baker-Ericzen et al., the culturally competent 
expansion of the PWH model, 55% of patients completed the treatment plan, 85% received 
psychoeducation, and 87% received emotional support.45 Gjerdingen et al. reported that their 
intervention had a significant positive impact on participants’ receipt of treatment and awareness 
of depression diagnosis.39 
Equity 
 Various components of equity were woven throughout the research, though it was 
explicitly mentioned in only 13 of the articles. Some authors commented on equity by indicating 
a specific at-risk population was served by the intervention, and others discussed equity as it 
relates to the acceptability or effectiveness of the intervention with a specific population. Two 
interventions focused on Latina women,45,46 two served African American women,64,66 and one 
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worked with female veterans.67 Several other interventions were conducted in settings that were 
described as ethnically diverse or predominately serving people of color.68,69 Six articles 
discussed interventions serving women without insurance, on Medicaid, or who are Medicaid-
eligible43,44,60–63,65 Two articles used a culturally tailored IBHC intervention called the Perinatal 
Mental Health Model (PMH).45,46 In these articles, a bicultural, bilingual mental health advisor 
was utilized to help address cultural barriers for the Latina patients. 45,46  
Katon et al. specifically stratified their collaborative care intervention versus usual care 
by insurance status and found that the treatment effect of the intervention on receipt of mental 
health services and recovery from depression symptoms was significantly associated with 
insurance status; the effect size for women with no insurance or public coverage recovering from 
depression symptoms in the intervention versus usual care was greater than for those women 
with commercial insurance.65 Connelly et al. indicated the Spanish-speaking mothers in the PMH 
intervention found the EPDS screening questions in Spanish to be clear and meaningful, and all 
mothers reported being satisfied with their mental health advisor.46 As mentioned above, over 30 
of the Latina mothers in the PMH intervention by Baker-Ericzen et al. spontaneously commented 
about how their mental health advisors helped them understand their depression and their unique 
cultural barriers related to depression.45  
DISCUSSION 
 Perinatal mood and anxiety disorders are a clear public health concern, with PMADs as 
the primary complication of pregnancy and an estimated 50% of PMAD cases going undetected 
or undiagnosed .1,2,8 Inconsistent screening practices, a shortage of mental health services and 
providers, childcare and transportation, insufficient follow-up protocols, mental health stigma, 
and insurance coverage are all barriers to properly assessing, treating, and managing 
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PMADs.1,7,17 Researchers have demonstrated that IBHC models are successful in treating 
depression in the adult population, and research from the past 10 years has added to the evidence 
supporting their use in a variety of other populations.31,32,34 Research regarding the use of IBHC 
with the perinatal population has begun to be established, as evidenced by recent systematic 
reviews;18,71 however, extensive literature reviews on this topic are still lacking. 
The results of this article review build on other systematic reviews from the past five 
years and indicate that IBHC interventions with the perinatal population are now well 
documented in the literature. The interventions that were included in this literature review served 
a diverse population, including African American women64,66 and Latina women,45,46 as well as 
women on Medicaid or without insurance.41,44,54,60–63,70 IBHC interventions also occurred in 
states across the country in a variety of urban and rural clinic settings, including hospital 
systems,35,42,55 federally qualified health centers,41,54 public health centers,45,60–63 and obstetric 
clinics,10,38,57,64,66,68,69 which suggests their generalizability across health care settings.  
 Not only did both patients and providers find IBHC interventions to be 
acceptable,38,39,45,49,52,59,61 but patients in the intervention groups also had greater improvement of 
depression symptoms44,59,61 and were more likely to receive behavioral health services.10,54,61 
Screening for depression with a validated tool, such as the PHQ-9 or EPDS, was also shown to 
be feasible with high screening rates43,51,54,68 and number of screens completed.40,42,47,48 This 
research suggests that IBHC models increase rates of screening with a validated tool. Based on 
the few articles that reported on costs, IBHC models appear to be cost-effective and financially 
sustainable.50,61,63 
 Ten of the 37 reviewed articles included Collaborative Care (CoC) Model interventions. 
While CoC has become the gold standard for IBHC models because of their extensive evidence 
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base, the low number of true CoC interventions in this review suggests there may also be some 
challenges to implementing this model. CoC involves a very specific set of components, 
including new job roles, patient tracking systems, and certain screening and re-screening 
guidelines, which may not be feasible or practical for all health care practices to employ. 
However, this research demonstrates the positive impact that some level of behavioral health 
integration offers to both patients and providers. Even if clinics are unable to fully integrate and 
execute a CoC intervention, some form of IBHC may increase their rates of screening for 
PMADs and decrease the likelihood of patients getting lost to follow-up. 
Limitations 
 Despite the extensive research that has been conducted for the use of IBHC with pregnant 
and postpartum women, the specific components of the interventions used in the research varied. 
Interventions included a mix of IBHC components, including systematic screening, the role of 
the care manager for tracking and follow-up with patients, behavioral health consultation, 
integration of medical records, and collocation of primary and mental health services. The 
diversity of possible IBHC components used across interventions makes it difficult to 
conclusively decide which components are crucial to their success and which are not. 
Furthermore, by having a spectrum of models and lacking a clear set of core components, 
interested health professionals may face challenges discerning how to successfully transition 
their health practices to this integrated model.  
The included studies in this literature review also reported on outcomes in vastly different 
ways. All interventions included some feasibility measures; however, acceptability outcomes and 
effectiveness outcomes were lacking from many of the studies. The ways in which studies 
reported on feasibility, acceptability, and effectiveness varied drastically from study to study. 
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Specific costs were also indicated in only three of the articles, though several others mentioned 
having cost analyses under way. Furthermore, many interventions did not include a comparison 
group, and reported solely on the changes seen in patients receiving the intervention.  
 Another limitation is that the vast majority of the studies included in this review focused 
on perinatal depression, and not on all PMADs. Only two studies included a validated tool to 
screen for anxiety as a part of an IBHC intervention, while all others were primarily screening 
for perinatal depression.64,66 Comorbid PTSD severity was a secondary outcome in one 
intervention.60 The intention for this review was to find interventions that targeted all PMADs; 
however, almost all of the studies found in the literature primarily or exclusively targeted 
perinatal depression. While the prevalence of perinatal depression is high, these other disorders 
occur in pregnant and postpartum women as well. Researchers and health care practitioners must 
also give adequate attention to anxiety, substance use, PTSD, and other disorders that impact the 
lives of perinatal women. Anxiety specifically may be of particular concern during the COVID-
19 pandemic as women have to navigate additional barriers and health concerns during their 
pregnancy and postpartum. Future interventions should also include systematic screening with 
validated tools for PMADs other than depression. 
 Lastly, despite multiple interventions targeting various at-risk populations and some 
demonstrating effectiveness and acceptability outcomes for low-income or minority women, the 
focus on equity in many IBHC interventions is severely lacking. The majority of the 
interventions included in this review did not speak to or address racism, cultural barriers, 
historical traumas, mistrust of medical communities, or other issues that are highly pertinent to 
the care that communities of color receive and their subsequent health outcomes. It is imperative 
that public health practitioners, researchers, and the medical community recognize the 
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importance of centering all work on equity. Without explicitly attending to equity in 
interventions and programs, practitioners risk perpetuating harms and health disparities. IBHC 
models must be implemented in equitable ways that address the multitude of patient-, clinic-, and 
system-level barriers that impact mental health screening, assessment, and treatment. This is 
especially important now as communities of color are particularly impacted by the COVID-19 
pandemic, and the US faces increasing demands for racial justice. 
Recommendations 
 Future researchers would benefit from focusing on a core set of IBHC components to 
implement in a variety of practice settings in order to increase the quality of the evidence 
supporting their use. The inclusion of more specific and consistent acceptability and 
effectiveness outcomes would also bolster the evidence base for the use of IBHC. Cost and 
financial sustainability measures were also lacking from the majority of the articles, which would 
be key feasibility outcomes to promote the use of IBHCs. By comparing more homogenous 
IBHC components and outcomes across interventions and settings, a stronger case could be made 
for the use of these models. 
It would also be beneficial for researchers to identify other process or outcome measures 
specifically concerning equity and health disparities in order to ensure that IBHC models are 
adequately addressing barriers that impact low-income and minority women. Additional 
qualitative data to understand patients’ personal experiences and feelings about their mental 
health treatment would be a rich and important addition to the evidence base. Lastly, COVID-19 
has brought about a new wave of telehealth and telepsychiatry, which has attended to some of 
the barriers that patients face to receiving care, while also bringing about new challenges. This 
may be an opportunity for IBHC, as some models already include remote behavioral health 
25 
 
consultation or psychiatric consultation. It is recommended that future research focus on these 
novel delivery methods and their impacts on patients, particularly those from vulnerable groups.   
Conclusion 
Despite the limitations regarding IBHC interventions’ diverse components, the lack of 
consistent outcome measures used in the research, and the little attention paid to PMADs other 
than depression, this literature review revealed over 35 studies showing IBHC models to be 
effective at ensuring comprehensive screening for perinatal depression and improving depression 
outcomes for pregnant and postpartum women. Increased communication between providers, 
more consistent screening practices, and systematic referral and follow-up protocols decrease the 
likelihood of patients falling through the cracks in the United States’ often disjointed and 
complex system of care. Offering services during prenatal or postpartum visits, or immediately 
before or after these appointments, helps to address some of the barriers that patients face to 
receiving care, such as cost of child care, access to transportation, and taking time away from 
work. By employing integrated behavioral health care models, health care providers have the 
best opportunity to positively impact the lives of all pregnant and postpartum women and 
effectively combat the major public health concern of perinatal mood and anxiety disorders.  
Appendix A: Description of IBHC interventions included in the literature review 











Partnership for Women's 
Health (PWH) Model: 
Systematic screening for 
maternal depression and 
centralized mental health 
advisor to advise, assist, 
and arrange follow-up with 
women (4As guidelines) 
Screening with EPDS 
(718 women screened); 
94% of those who 
screened positive 
received mental health 
advisor services 
92 mothers contacted for satisfaction 
eval, 90% completed this; reported 
mental health advisor contacted them in 
timely manner; 99% said they felt 
comfortable talking about condition with 
provider; 96% liked that OB or 
pediatrician was concerned about their 
mood; 91% reported mental health 
advisor was helpful 
Behavior changes at 3-week follow-
up call (96% of mothers); 46% had 
participated in support groups or 
classes, 35% had received 

















Perinatal Mental Health 
Model--culturally 
competent expansion of 
the original PWH model; 4 
A's; bilingual, bicultural 
Mexican American mental 
health advisors to address 
barriers 
74% were reached by 
phone and received 
intervention; all 
received screening with 
EPDS 
Over 30 mothers spontaneously 
commented about the study: positive 
statements about impact of 
understanding depression and cultural 
barriers prior to the program related to 
depression; 97% reported MHA was 
knowledgeable about depression; 97% 
reported overall satisfaction; 100% rated 
MHA service as high quality 
55% of patients completed 
treatment plan; 85% received 
psychoeducation, 49% received info 
normalizing depression, 87% 
received emotional support 
Bhat et al. 
(2018)69  










Rural OB clinic; 
Washington 
modified Depression 
Attention for Women Now 
(DAWN) Collaborative Care 
(CoC) intervention; 
universal screening with 
PHQ-9, care manager gave 
engagement sessions, 
problem-solving therapy, 
and info on mental 
health/pharmacotherapy; 
encounters in clinic or in 
patient home 
Universal depression 
screening with PHQ-9 
Surveys and focus groups with patients 
and providers; 83% of providers felt CC 
had improved clinical outcomes; in focus 
groups with patients, common theme 
was receiving depression care in OB 
setting to be appropriate 
Change in PHQ9 scores from 
baseline to study end, rates of 
depression remission, and 
proportion with more than 50% 
reduction; 80% had scores less than 
10 and 64% saw more than 50% 
reduction in scores, 32% had scores 
less than 5 
Bhat et al. 
(2018)68 






Rural OB clinic; 
Washington 
modified DAWN CoC 
intervention; analyzes text 
messaging to communicate 
with care manager 
CMs initiated 85.4% of 
texts, patients 
responded to 86.9% of 
Patients reported appreciating 





texts; screening with 
PHQ-9 
Bhat et al. 
(2020)58 
















coaching to support 
implementation of 
perinatal CoC; psychiatrist 
with expertise in CoC 
coached local clinical team 
in systematic case review 
via video 
58% LRC sessions 
occurred during 
recommended 




made by LRC 
psychiatrist 
Participants reported LRC supported 
better patient care and supported their 
application of new skills into systems-
based practice 
N/A 











MCPAP for Moms: trainings 
and toolkits for depression 
screening (EPDS or PHQ9), 
perinatal psychiatric 
consultation via phone, 
care coordination for 
women 
Telephone consultation 
resulted in provider 
continuing to manage 
patient (78%), referral 
for therapy (38%), care 
coordination (36%), 
referral to psychiatrist 
(18%); conducted 100 
trainings, enrolled 87 
practices, served 1123 
women in the first 
month; costs $8.38 per 
woman per year; 
screening with EPDS or 
PHQ-9 
N/A N/A 
Byatt et al. 
(2017)59  
4 OB practices; 









4 OB practice; 
Massachusetts 
PRISM (vs. MCPAP for 
Moms): MCPAP for Moms 
program plus additional 
training, implementation 
support, toolkits for 
technical assistance, 
change management 
support, and more follow-
up components 
Systematic screening 
with EPDS or PHQ-9 
Percentage of providers certain in their 
ability to effectively treat OB patients 
with depression increased in both groups 
(but higher in PRISM), and % who 
reported having knowledge and skills to 
detect and address depression increased 
significantly; 97% of patients agreed or 
strongly agreed depression screening 
results were discussed with them in a 
supportive way; 76% reported there was 
EPDS scores improved in both 
groups, but more so in PRISM group 
(not statistically significant because 
of small sample size) 
 
 
never a time when they felt that they 













study   
2 OB practices; 
California 
PMH model and the 4A's; 
systematic screening; 
referral of positive screens 
to bilingual mental health 
advisors (MHA); telephone 





Screening with EPDS 
and other validated 
tools; Of 7 who 
screened positive, MHA 




100% reported high satisfaction with 
MHA contact; mothers reported 
screening questions in Spanish were 
clear and meaningful, and they were 
receptive to MHA treatment 
recommendations 
Those who screened positive and 
were reached by phone and 
diagnosed received 
psychoeducation, discussion of 
treatment options, linkage to 
services 





women (223 in 
2012, 472 in 
2013) 




practitioner embedded in 
OB clinic to provide 
psychiatric consultation 
and treatment; treatment 
algorithm developed to 
support and guide the use 
of EPDS, other treatment 
approaches, and referrals; 
free support groups 
Universal screening 
with EPDS; screen-
positive women were 
further evaluated for 
additional services; 
number of women 
referred to and seen by 
NP increased by 47% in 
year 1 
N/A Women who screened positive 









1 OB practice; 
Michigan 
Treating physical notified 
of elevated EPDS status; 
depression education and 
referral info delivered; 
referral to on-site social 
workers for psychotherapy 
or further referral to 
psychiatry 
95% screened for 
depression with EPDS; 
67% of women with 




N/A Change from 14 to 39% of women 
receiving any depression treatment 
from baseline; those who screened 
positive AND had discussed with 
physician were more likely to have 














Stepped CoC; screening, 
diagnosis, and treatment in 
primary care setting, and 
care manager follow-up 




completed PHQ-9 and 
Structured Clinical 
Interview for DSM-IV 
(SCID) 
Both groups satisfied with their 
treatment 
Intervention had significant positive 
impact on receipt of treatment and 
















Fully integrated obstetric 
mental health clinic; 
screening, assessment by 
on-site LCSW, further 
evaluation and medication 
support/treatment with 
on-site perinatal mental 
health nurse practitioner 
Depression measured 
at baseline and follow-
up with EPDS 
Qualitative themes from telephone 
interviews with 9 women: safe place, 
mental/emotional stability, integrated 
personalized approach; providers (31) 
reported perceiving the clinic to be 
helpful and improved access to mental 
health care 
72% experienced less depression by 
first follow-up; women with highest 
levels of baseline depression had 









Multisite RCT 10 public health 
centers; Oregon 
MOMCare CoC with 
depression care managers; 
designed to decrease 
mental health treatment 
disparities in access to and 
quality of care; pretherapy 
engagement session, 
choice and access to 
pharmacotherapy and/or 
brief interpersonal therapy; 
systematic outreach and 
measurement 
Screening with PHQ-9 MOMCare participants reported greater 
satisfaction on average with all 
depression care received across follow 










Multisite RCT 10 public health 
centers; Oregon 
MOMCare vs. MSS Plus 
(see above) 
Screening with PHQ-9 MOMCare participants reported greater 
satisfaction on average with all 
depression care received across follow 
up period  
93% completed at least 4 sessions, 
and 84% completed at least 8 
sessions; 79% had at least 1 
maintenance session; MOMCare 
participants had significantly higher 
rates of depression remission and 
lower levels of depression severity 
compared to MSS Plus participants; 
MOMCare participants more likely 
to receive at least 4 or more mental 
health visits; both groups 
experienced reduction in PTSD over 










Multisite RCT 10 public health 
centers; Oregon 
MOMCare vs. MSS Plus 
(see above) 
Screening with PHQ-9 MOMCare participants reported greater 
satisfaction on average with all 
depression care received across follow 
up period  
Specifically looked at co-morbid 
PTSD; 65% of the sample met 
criteria for probable PTSD; over 18 
months of follow-up, those with 
comorbid PTSD in MOMCare vs. MSS 
 
 










Multisite RCT 10 public health 
centers; Oregon 
MOMCare vs. MSS Plus 
(see above) 
Screening with PHQ-9 MOMCare participants reported greater 
satisfaction on average with all 
depression care received across follow 
up period  
Benefit-cost of intervention by gain 
in depression free days (women with 
comorbid depression and PTSD had 
68 more depression-free days over 
18 months than those in MSS Plus. 
Additional cost per MOMCare 
participant was $1,312. Incremental 
net benefit of the intervention was 








523 usual care) 





before or after 8 routine 
prenatal care sessions; 
group CBT for depression; 
pregnancy advisors help 
develop work plans for 
take-home tasks; measured 
risk factors of smoking, 
environmental tobacco 
smoke exposure, 
depression, and IPV before 
and after intervention 
Beck Depression 
Inventory II and 
Hopkins Symptom 
Checklist used for 
depression screening 
93% of subsample had a positive view of 
their relationship with their counselor 
and most found the session content 
helpful 
Two methods of quantifying 
behavioral change (0-4 risks)—
number of risks reported by women 
in the two groups at baseline and at 
first and second follow-up; 
quantified within-person change 
over time (58% of women in 
intervention group resolved some or 
all of their risks vs. 48.2% of those 
with usual care) 
Katon, J. et 
al. (2017)67 
199 pregnant 
or <8 weeks 
postpartum 
women; 












systematic screening (3 
times), maternity care 
coordinator, onsite LCSW 
and onsite OB/GYN 
Screening with EPDS 3 
times during perinatal 
period; those at VAMC 
were more likely to 
complete at least one 
screen for depression 
than those in 
community care 
N/A 88% of those with pre-pregnancy 
mental health diagnosis and 
depressive symptoms received 
outpatient mental health care and 
77% met with LCSW; none of those 
without pre-pregnancy diagnosis 
received outpatient care, but 77.8% 








RCT 2 OB practices; 
Washington 
CoC model; care manager 
delivered engagement 
session, psychotherapy vs 
med treatment, education, 
outreach; tracked and 
Screening with PHQ-9 CoC group more satisfied with quality of 
depression care than usual care patients 
(both insurance groups) with greatest 
74% of patients with commercial 
insurance attended at least 4 mental 
health visits, 81% of patients with 
no/public insurance attended at 





follow-up with over 12 
months; usual care 
included education 
pamphlet and social work 
referral 
difference in satisfaction in commercially 
insured 
associated with insurance status); 
those with no/public insurance had 
greater recovery from depression 
symptoms over 18 months; 
differences in antidepressant use 
consistency between intervention 
and usual care greater among 
uninsured/public insurance; those 
with no insurance or public coverage 
had greater recovery from 
depression symptoms with CoC than 
with usual care over 18 months 
follow up; effect size at 12 months 
was 0.81 compared to 0.39 for 
women with commercial insurance 






523 usual care) 
RCT 6 OB practices; 
Washington, 
D.C. 
DC-Hope (same as Joseph 
study) intervention 
delivered during 8 routine 
prenatal care sessions; 
group CBT for depression; 
pregnancy advisors met 
with participants to 
develop work plans for 
between sessions 
Beck Depression 
Inventory II and 
Hopkins Symptom 
Checklist used for 
depression screening 
93% of subsample had a positive view of 
their relationship with their counselor 
and most found the session content 
helpful 
84% of women attended at least one 


















with PHQ or EPDS, referral 
to care manager, case 
management and 
connection to other 
services 
More than 8500 preg 
or pp women screened 
with EPDS or PHQ-9 
between Dec. 2007 and 
2009 (overall rate of 
54%); 57% referred to 
care manager for 
positive screen 
N/A 46% of referred women engaged in 







Pilot study Urban pediatric 
clinic; North 
Carolina 
Maternal mental health 
clinic within pediatric 
practice; case manager and 
psychiatrist; systematic 
screening at well-baby 
visits, and assessment; text 
messaging available with 
Screening with US 
Preventive Services 
Task Force 2-item 
screener; more than 
half communicated 
with case manager via 
N/A Nearly half of participants attended 
at least 4 sessions with psychiatrist 
in 6 months; more than 90% 
attended more than 1 visit 
 
 
case manager; on-site 
treatment 













(first at the 
hospital, then 
expanded to 7 
community 
clinics and 3 
Women's Care 
clinics in a 
stepwise 
fashion) 
Integrated Perinatal Mental 
Health program for all 
women served in hospital; 
universal screening using 
EPDS (2x during preg., and 
at 6-week pp visit); same-
day visit w/ behavioral 
health provider (warm 
hand-off or co-visit); brief 
focused therapies and 
assistance with 
referrals/case management 
PMAD screening using 
EPDS (rates range from 
89-100% at first 
prenatal care visit, and 
61-100% at postpartum 
visit); over 75% of 
women screened in 
2016 across all clinics 
anecdotal feedback from providers has 
been positive 
Between August 2014 and 
December 2017, ~5350 behavioral 
health visits were billed co-occurring 
with a medical visit; in one clinic, 
48% of patients were seen one time 
for behavioral health appointment, 












engagement with local 
behavioral health 
consultants; connect 
providers to psychiatrists 
specializing in perinatal 
mental health or child 
mental health; 
recommendations made to 
PCP 
From 2012 to 2018, 
2,121 PCPs in 519 
clinics enrolled; 10,445 
service requests for 





97% of PCPs enrolled report being 
satisfied; PCPs report high level of 







103 usual care) 
RCT 2 OB clinics; 
Washington 
DAWN intervention; 
depression care managers 
(social workers) provide 
psychotherapy and track 
patients (meds, 
compliance, etc.); initial 
engagement session, 
outreach, choice of 
treatment, telephone visits 
Screening with PHQ-9; 
96% had at least one 
depression care 
manager visit  
Intervention patients reported greater 
satisfaction with depression care 
Intervention group more likely to 
receive at least 4 specialty mental 
health visits; Greater reduction in 
depression symptoms in 
intervention group at 12 and 18 
months; more likely to have at least 
50% decrease in depressive 
symptoms at 12 month; 53.9% 













algorithm to help guide 
decision-making, 
pharmacotherapy 
guidelines, phone support, 
Screening with EPDS; 
Mean of 62.5% (of all 
eligible women) 
completed screens 
throughout 7 months 
1.4% refused assessment and lack of 









consultation; monitoring to 
track missed screening and 
assessment opportunities 
of the study; mean of 



















Provider training, case 
management, screening 
with PHQ-9, on-site 
assessment following 
screen during the same 
visit; engagement 
strategies and resources, 
mental health consultation 
via phone 
Screening rates with 
PHQ-9 compared 
before and after 
intervention, 65.2% 
screened prior, 93.5% 
screened after; Rates of 
clinician performed 
interviews/assessments 
after positive screens 
increased from 10-85% 
during intervention 
N/A Among patients diagnosed with 
















Common medical records, 
standardized screening, 
referral to women's mental 
health center; different 
levels of integration at 
different practices (co-
location, full integration, 
no interaction but shared 
EMR); psychiatrists on-call 
for consultations and 
questions 
Total of 102,906 
screens (EPDS) 
completed between 
May 2014 and July 
2018; 3,893 of 6,487 
screen positive women 
referred for treatment 
N/A 55.8% women of the 3,893 referrals 
completed an appointment for 
mental health services within 60 
days of referral  
Rock 
(2019)55 












Screening and evaluation 
on-site; collocated nurse 
practitioner and 
psychiatrist; connection to 
support groups, medication 
and/or therapy; patient 
education; referral services 
Screening with EPDS N/A 80% of prenatal patients had 




women (569 w/ 






medical org, 19 
OB clinics; Texas 
Systematic screening, 
engagement strategies, 
resources and referrals, 
and systematic follow-up 
with patients 
All 2199 women 
screened with EPDS 
N/A Number who pursued further 













3 OB practices; 
Pennsylvania 
Systematic screening; 
depression care manager 
offered on-site assessment, 
referrals, case 
management, engagement 
strategies and education 
for screen-positive women 
Screening with PHQ9 Patient satisfaction high with 
intervention 
31.9% of patients had kept or 
scheduled a new mental health 



















health clinician (via video 
conferencing) who was 
care manager and provided 
brief 
interventions/treatments 
and referrals for ongoing 
services; psychiatrist 
provided consultations; 
OB/GYN prescribed meds 
based on consultations 
100% completed 
depression screening 
(EPDS and PHQ-9) and 
all elevated scores 
referred for program 
services; care manager 
made 834 contacts 
with patients (avg. of 6 
per patient) 
16 completed satisfaction surveys; 
majority reported good experiences and 
would recommend telehealth to others 
96% of referred patients engaged in 
behavioral health treatment; of 
patients eligible for delivery services 
at clinic, 86% delivered full-term 
babies and 12% were low birth 
weight 






insurance or on 
Medicaid; no 
comparison 




Collocation of psychiatrist 
in OB clinic; Screening, 
psychiatric evals on site for 
screen-positive women, 
initiated pharmacotherapy 
or depression management 
skills training, ongoing 
consultation and materials 
for staff 
Screening with EPDS; 
diagnosis/assessment 
with PRIME-MD for 
those with positive 
screens (29) 
Patient Satisfaction (reported high levels, 
mean score 33 out of 35) 
Reduction of symptoms (patients 
reported a reduction in symptoms 















Universal screening and co-
located behavioral health 
services 
Screening with EPDS, 
semi-structured 
interviews conducted 
after positive screen; 
18 providers had 
documented plans for 
addressing depressive 
symptoms; Social work 
referrals offered to 12 
women who identified 
Patients' self-reported perception of 
providers' response (most reported 
appreciating having their provider talk 
with them about their symptoms and felt 
supported; most expected follow-up at 
next appt. 
10 received some sort of treatment 
for depression; only 8 of 20 were re-
administered the EPDS at follow-up 
 
 
unmet social needs (9 
seen my social worker) 
Truitt et al. 
(2013)56 
78 women (15 




5 primary care 
facilities; 
Minnesota 
Screening, referral for 
mental health evaluation, 
treatment as part of CoC 
program (vs. routine PPD 
care); treatment follow-up 
Screening with EPDS or 
PHQ-9 
N/A CC group had mean of 13 mental 
health visits, 100% had at least 3 
follow up contacts; CCM group more 
likely to have three or more contacts 
in first three months after diagnosis; 
Days to first follow-up (those in CCM 
had fewer days to first follow up 6.1 
vs 31.4), remission rates (46.7% 











3 OB practices; 
Massachusetts 
Screening, referral to on-
site LCSW for mental 
health evaluation and 
treatment initiation 




all positive screens 
referred for evaluation 
and treatment (100%); 
evaluation by mental 
health professional 
(79%) 
N/A 35% treated with an antidepressant; 
women who screened positive 
antepartum were significantly more 
likely to be linked to mental health 
services compared with women who 
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